Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

Understanding calcified coronary artery disease, its risk factors, symptoms, diagnosis, treatment, and prevention for a ...

A major international study has found that heart patients, particularly seniors, may benefit more from newer blood-thinning ...

[2,11,25,42] However, the main limitation of durable polymers are that they remain exposed for long periods of time to the coronary artery ... biodegradable polymer stents have been developed ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

Taking low-dose aspirin can help reduce your risk of heart attack and stroke if you have cardiovascular disease, according to ...

Team's approach underscores urgency of comprehensive management to confront myriad challenges of the condition ...

Clinicians from both cardiology and primary care talked about the value of ongoing communication, respect to achieve ...

The cardiovascular devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving ...

San Clemente, California Saturday, May 31, 2025, 16:00 Hrs [IST] ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart ...